Interrelationship between diabetes and homocysteine metabolism: Hormonal regulation of cystathionine β-synthase

Nutrition Reviews

Volumn 61, Issue 4, 2003, Pages 136-138

  Schalinske, Kevin L ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Cystathionine synthase; Diabetes; Homocysteine; Insulin; Transsulfuration

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLIC AMP; CYSTATHIONINE BETA SYNTHASE; GLUCAGON; GLUCOCORTICOID; HOMOCYSTEINE; INSULIN; TRIAMCINOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; HEP 2 CELL; HORMONAL REGULATION; HYPERHOMOCYSTEINEMIA; INSULIN TREATMENT; KIDNEY FAILURE; METABOLISM; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; RISK FACTOR; SHORT SURVEY; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; ANIMAL; BLOOD; GENE EXPRESSION REGULATION; GENETICS; HUMAN; REVIEW;

ANIMALS; CYSTATHIONINE BETA-SYNTHASE; DIABETES MELLITUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMOCYSTEINE; HUMANS; RATS;

EID: 0042887610     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2003.apr.136-138     Document Type: Short Survey

References (16)

1. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
2. Kang S-S, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 1992;12:279-298.
3. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: a risk factor for neural tube defects? Metabolism. 1994;43:1475-1480.
4. Huysmans K, Lins RL, Daelemans R, Zachee P, DeBroe ME. Hypertension and accelerated atherosclerosis in endstage renal disease. J Nephrol. 1998;11:185-195.
5. Lien EA, Nedrebo BG, Varhaug JE, Nygard O, Aakvaag A, Ueland PM. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab. 2000;85:1049-1053.
6. Nedrebo BG, Ericsson UB, Nygard O, et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism. 1998;47:89-93.
7. Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Plasma homocysteine is decreased in the hypothyroid rat. Can J Physiol Pharmacol. 2000;78:565-570.
8. Shulpis KH, Karikas GA, Georgala S, Michas T, Tsakiris S. Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne. Int J Dermatol. 2001;40:33-36.
9. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-246.
10. Hofmann MA, Kohl K, Zumbach MS, et al. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care. 1997;20:1880-1886.
11. Robillon JF, Canivet B, Candito M, et al. Type 1 diabetes mellitus and homocyst(e)ine. Diabetes Metab. 1994;20:494-496.
12. Poirier LA, Brown AT, Fink LM, et al. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism. 2001;50:1014-1018.
13. Jacobs RL, House, JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and insulin treatment on homocysteine metabolism in the rat. Diabetes. 1998;47:1967-1970.
14. Dickman-Brown A, Fonseca VA, Fink LM, Kern PA. The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-β-synthase: studies in hepatocytes. Atherosclerosis. 2001;158:297-301.
15. Jacobs RL, Steads, LM, Brosnan ME, Brosnan JT. Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J Biol Chem. 2001;276:43740-43747.
16. Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT. Hormonal regulation of cystathionine β-synthase expression in liver. J Biol Chem. 2002;277:42912-42918.